Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Sadif Analytics (Premium)
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Merge Healthcare Inc Reaffirms FY 2013 Guidance-Conference Call


Tuesday, 19 Feb 2013 01:30pm EST 

Merge Healthcare Inc announced that for fiscal 2013, it expects pro forma revenue between $265 million and $275 million, and adjusted EBITDA growing to 22% to 24%. The Company reported EBITDA of $52.49 million in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $265 million for fiscal 2013. 

Company Quote

2.58
0.02 +0.78%
28 Aug 2014